用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| WB | Western blot analysis of extracts from HEK293T (lane 2(20μg), HEK293T (lane 3(40μg), using PIAS1 Antibody. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in TBST for 2 hour at room temperature. The primary antibody and Loading control antibody (Beta Actin, HY-P80438, 1/3000) was used in 5% BSA in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (HY-P8004/HY-P8001, 1/10,000) was used for 1 hour at room temperature. |
| IHC-P | Immunohistochemical analysis of paraffin-embedded Mouse brain tissue using PIAS1 Antibody (YA2217). The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) for 2 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HY-P82472, 1/100) in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. |
| FC | Flow cytometric analysis of 1X10^6 Hela cells labeling PIAS1 Antibody (YA2217) (HY-P82472, red). Cells were fixed with 4% paraformaldehyde and permeabilised with intranuclear rupture fluid. Then stained with the primary antibody at 1/50 dilution for an hour at 4℃. Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L ( HY-P8002 ) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Rabbit IgG Isotype Control (HY-P80879, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black). |
| ICC | Immunocytochemistry analysis of HeLa cells labeling PIAS1 with PIAS1 antibody ( HY-P82472 ) at 1/50 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with BSA for Immunol Staining for 10 min at room temperature. Cells were then incubated with PIAS1 antibody ( HY-P82472 ) at 1/50 dilution in BSA for Immunol Staining at 4 ℃, Stay overnight. AF488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). Immunocytochemistry analysis of HeLa cells labeling PIAS1 with PIAS1 antibody ( HY-P82472 ) at 1/100 dilution. Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 for 10 minutes at room temperature, then blocked with BSA for Immunol Staining for 10 min at room temperature. Cells were then incubated with PIAS1 antibody ( HY-P82472 ) at 1/100 dilution in BSA for Immunol Staining at 4℃, Stay overnight. AF488-conjugated AffiniPure Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue). |
推荐稀释比例
- WB1:500-1:1000
- IHC-P1:50-1:100
- ICC/IF1:50-1:200
- FC1:50-1:100
详细信息
背景信息
功能: PIAS1 发挥 E3 型小泛素样修饰物 (SUMO) 连接酶的功能,稳定 UBE2I 与底物之间的相互作用,同时也作为 SUMO 锚定因子发挥作用。它可催化多种蛋白的 SUMO 化修饰,如 CEBPB、MRE11、MTA1、PTK2 和 PML。PIAS1 在多种细胞通路 (包括 STAT 通路、p53 通路和类固醇激素信号通路) 中作为转录共调节因子发挥关键作用。体外实验显示它可结合富含 A/T 的 DNA。这种转录共调节作用 (转录激活或沉默) 可能因生物学背景不同而存在差异。 PIAS1 介导 MRE11 的 SUMO 化修饰,在末端切除过程中稳定染色质上的 MRE11。它可对 PML (在 Lys-65 和 Lys-160 位点) 和 PML-RAR 进行 SUMO 化修饰,促进它们经泛素介导的降解 (同源推断)。PIAS1 介导的 PML SUMO 化可促进 PML 与 CSNK2A1/CK2 的相互作用,进而促进 PML 的磷酸化和降解 (同源推断)。PIAS1 可增强 MTA1 的 SUMO 化修饰,可能参与其旁系同源选择性 SUMO 化过程。 PIAS1 通过促进 CEBPB 的 SUMO 化和降解,在脂肪生成中发挥动态调控作用 (同源推断)。它介导 MSX1 的核迁移和向核 periphery 的定位,从而将 MSX1 带到靶标成肌细胞分化因子基因的邻近区域 (同源推断)。PIAS1 还参与 MSX1 与靶基因启动子区核心增强子区域的结合,该功能不依赖于其 SUMO 化活性 (同源推断)。它能够结合 MYOD1 基因启动子中的核心增强子区域 TAAT 盒 (同源推断)。 (微生物感染相关) PIAS1 通过抑制裂解期基因表达相关的转录因子,限制 EB 病毒 (EBV) 的裂解复制。病毒可利用凋亡半胱天冬酶拮抗 PIAS1 介导的限制作用,从而表达其裂解期基因 [1] [2] [3] [4] [5] [6] [7] 。 亚细胞定位: 细胞核;核斑;细胞核,PML 体;细胞质,细胞骨架 表达水平: 组织特异性:在多种组织中表达,在睾丸中表达水平最高 异构体 & 翻译后修饰: O75925 有 3 种异构体:O75925-1:71836 Da (预测值);O75925-2:72203 Da (预测值);O75925-3:36204 Da (预测值)。 SUMO 化 亚基: 与 NCOA2 和 AR 相互作用。与 NR2C1 相互作用;该相互作用促进其 SUMO 化 (基于相似性)。在 IFNA1 刺激后,与 DDX21、CSRP2、AXIN1、JUN、UBE2I、SUMO1、SATB2、PLAG1、TP53 和 STAT1 (二聚体) 相互作用。与 SP3 相互作用 (优先在 SUMO 修饰时)。与 KLF8 相互作用;该相互作用导致 SUMO 连接,并抑制 KLF8 的转录活性及其细胞周期进程进入 G1 期。与 CHUK/IKKA 相互作用;该相互作用诱导 PIAS1 磷酸化。与 PTK2/FAK1 相互作用;该相互作用促进其 SUMO 化。与 DDX5 相互作用。与 PML 相互作用 (基于相似性)。与 MTA1 相互作用。与 SUMO1P1/SUMO5 相互作用 (PubMed:27211601)。与 PRDM1/Blimp-1 相互作用 (PubMed:28842558)。通过 N 端与 MSX1 (通过 C 端) 相互作用;这种相互作用对于两种蛋白定位到核周以及 MSX1 与靶基因启动子核心增强子区域的特异性结合是必需的 (PubMed:16600910)。